---
$id: https://graph.org.ai/products/commodity/51182213
$type: Product
source: UNSPSC
code: "51182213"
title: "Meteneprost"
class: "51182200"
classTitle: "Drugs for inducing labor"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Meteneprost

**UNSPSC Code**: 51182213
**Class**: [Drugs for inducing labor](Drugs for inducing labor.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue with the molecular formula C23H38O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 269EB4R1TV, chemically known as 9-methylene-11r,15s-dihydroxy-16,16-dimethyl-5z,13e-prostadienoic acid but generally known as meteneprost, which bears US NIH Compound Identifier 5283060. European Medicines Agency schedules Meteneprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08822MIG. The term METENEPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). METENEPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meteneprost under HS 29375000 and SITC 54156. As of Q4 2014, METENEPROST remains the US FDA Preferred Term for this commodity. Meteneprost bears US NLM identifiers UMLS ID C0127783 and NCI Concept Code C90926. SMILES: OC1C(C(C(=C)C1)C/C=C\CCCC(=O)O)/C=C/C(O)C(CCCC)(C)C.

